BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
Daily Return during Q2 2024
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | -12.32% | -11.60% | 21.54% | -11.51% | -9.06% | -17.02% | 0.30% | 3.09% | 14.54% | 04/07/2010 |
BIB NAV | -12.42% | -11.61% | 21.43% | -11.70% | -9.07% | -16.99% | 0.24% | 3.07% | 14.53% | 04/07/2010 |
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 5/17/2024- NAV $57.04
- NAV Change $-0.52
- Market Price $57.05
- Market Price Change $-0.44
- Trading Volume (M) 9,075
- 30-Day Median Bid Ask Spread 0.21%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 5/17/2024- NAV $57.04
- NAV Change $-0.52
- Market Price $57.05
- Market Price Change $-0.44
- Trading Volume (M) 9,075
- 30-Day Median Bid Ask Spread 0.21%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 3/28/2024
Holdings
as of 5/17/2024
Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
---|---|---|---|---|---|---|
45.72% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 41,723,114 | -- | 9,412 | -- |
36.07% | -- | NASDAQ BIO INDEX SWAP BNP | 32,914,802 | -- | 7,425 | -- |
18.91% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 17,257,552 | -- | 3,893 | -- |
14.71% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 13,427,466 | -- | 3,029 | -- |
6.42% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,855,953 | -- | 1,321 | -- |
6.40% | AMGN | AMGEN INC | -- | $5,837,564.54 | 18,682 | 2023607 |
5.93% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $5,413,308.39 | 12,159 | 2931034 |
5.84% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 5,328,430 | -- | 1,202 | -- |
5.70% | REGN | REGENERON PHARMACEUTICALS | -- | $5,202,207.84 | 5,296 | 2730190 |
5.26% | GILD | GILEAD SCIENCES INC | -- | $4,804,666.28 | 70,949 | 2369174 |
3.63% | MRNA | MODERNA INC | -- | $3,316,253.70 | 24,953 | BGSXTS3 |
3.32% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 3,027,719 | -- | 683 | -- |
3.20% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,924,199.40 | 38,026 | 2989044 |
2.40% | BIIB | BIOGEN INC | -- | $2,188,570.44 | 9,492 | 2455965 |
1.35% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,228,964.40 | 8,226 | B00FWN1 |
1.26% | ILMN | ILLUMINA INC | -- | $1,152,351.25 | 10,375 | 2613990 |
1.05% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $955,384.08 | 12,318 | 2437071 |
1.01% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $925,027.29 | 6,501 | 2623911 |
0.95% | SNY | SANOFI-ADR | -- | $870,657.63 | 17,889 | 2964557 |
0.93% | VTRS | VIATRIS INC | -- | $851,509.98 | 77,551 | BMWS3X9 |
0.92% | UTHR | UNITED THERAPEUTICS CORP | -- | $843,349.50 | 3,075 | 2430412 |
0.92% | INCY | INCYTE CORP | -- | $837,371.50 | 14,665 | 2471950 |
0.88% | SRPT | SAREPTA THERAPEUTICS INC | -- | $805,359.40 | 6,130 | B8DPDT7 |
0.87% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $795,520.44 | 29,172 | BMVP7Y0 |
0.87% | MEDP | MEDPACE HOLDINGS INC | -- | $790,533.00 | 2,010 | BDCBC61 |
0.81% | ARGX | ARGENX SE - ADR | -- | $742,960.11 | 2,031 | BDVLM39 |
0.65% | ROIV | ROIVANT SCIENCES LTD | -- | $590,967.52 | 52,624 | BMW4NZ9 |
0.63% | BNTX | BIONTECH SE-ADR | -- | $572,745.81 | 6,321 | BK6H543 |
0.58% | PCVX | VAXCYTE INC | -- | $527,731.89 | 7,077 | BKPVGH6 |
0.51% | BGNE | BEIGENE LTD-ADR | -- | $467,386.40 | 2,704 | BYYWPW6 |
0.50% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $454,442.24 | 3,752 | BV9G6B8 |
0.49% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $443,589.30 | 4,070 | B4Q5ZN4 |
0.46% | RVMD | REVOLUTION MEDICINES INC | -- | $423,933.37 | 10,757 | BL71K91 |
0.46% | BPMC | BLUEPRINT MEDICINES CORP | -- | $419,840.00 | 4,000 | BWY52P3 |
0.45% | EXEL | EXELIXIS INC | -- | $414,059.82 | 19,802 | 2576941 |
0.45% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $411,125.00 | 6,325 | BHCB0P4 |
0.44% | CYTK | CYTOKINETICS INC | -- | $400,220.19 | 6,723 | BBBSBJ5 |
0.41% | HALO | HALOZYME THERAPEUTICS INC | -- | $370,198.80 | 8,280 | 2975098 |
0.39% | IONS | IONIS PHARMACEUTICALS INC | -- | $355,228.51 | 9,521 | BDJ0LS6 |
0.38% | BBIO | BRIDGEBIO PHARMA INC | -- | $345,463.29 | 11,481 | BK1KWG8 |
0.37% | IBRX | IMMUNITYBIO INC | -- | $333,555.30 | 43,602 | BNSP0B8 |
0.36% | APLS | APELLIS PHARMACEUTICALS INC | -- | $325,440.18 | 7,878 | BYTQ6X1 |
0.33% | KRYS | KRYSTAL BIOTECH INC | -- | $302,764.50 | 1,845 | BD6JX35 |
0.32% | CRSP | CRISPR THERAPEUTICS AG | -- | $294,761.46 | 5,243 | BDHF4K6 |
0.32% | IMVT | IMMUNOVANT INC | -- | $291,250.90 | 9,487 | BJRFSB7 |
0.31% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $286,298.06 | 1,301 | BD59BS7 |
0.30% | NUVL | NUVALENT INC-A | -- | $271,541.28 | 3,831 | BMVBZD3 |
0.29% | ALKS | ALKERMES PLC | -- | $263,476.50 | 10,910 | B3P6D26 |
0.26% | INSM | INSMED INC | -- | $240,145.15 | 9,695 | 2614487 |
0.26% | AXSM | AXSOME THERAPEUTICS INC | -- | $236,661.68 | 3,092 | BYZR4X4 |
0.26% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $235,057.80 | 5,205 | BMX9K07 |
0.26% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $233,715.80 | 4,547 | BDD19F8 |
0.25% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $225,176.86 | 5,378 | BJ62Z18 |
0.24% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $215,949.44 | 4,816 | BGMGM89 |
0.22% | SMMT | SUMMIT THERAPEUTICS INC | -- | $203,449.68 | 45,822 | BMTVQS7 |
0.22% | GH | GUARDANT HEALTH INC | -- | $201,586.64 | 7,949 | BFXC911 |
0.22% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $200,463.61 | 8,093 | BYQBFJ8 |
0.22% | IDYA | IDEAYA BIOSCIENCES INC | -- | $197,113.50 | 4,867 | BK0VHF6 |
0.21% | XENE | XENON PHARMACEUTICALS INC | -- | $196,054.80 | 4,926 | BRJ3GY4 |
0.20% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $186,777.60 | 18,240 | BF0DMK7 |
0.20% | DNLI | DENALI THERAPEUTICS INC | -- | $186,374.37 | 9,087 | BD2B4V0 |
0.20% | ACLX | ARCELLX INC | -- | $184,774.52 | 3,446 | BPCJ1Q2 |
0.20% | FOLD | AMICUS THERAPEUTICS INC | -- | $184,595.73 | 19,289 | B19FQ48 |
0.19% | TWST | TWIST BIOSCIENCE CORP | -- | $177,509.76 | 3,776 | BGKG6G7 |
0.18% | MRUS | MERUS NV | -- | $166,023.71 | 3,781 | BZBY005 |
0.18% | PTCT | PTC THERAPEUTICS INC | -- | $165,541.19 | 5,002 | B17VCN9 |
0.18% | NTLA | INTELLIA THERAPEUTICS INC | -- | $164,609.16 | 6,278 | BYZM6C2 |
0.17% | FTRE | FORTREA HOLDINGS INC | -- | $159,679.80 | 5,796 | BRXYZ57 |
0.17% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $159,199.56 | 10,764 | 2713317 |
0.17% | JANX | JANUX THERAPEUTICS INC | -- | $155,806.80 | 3,308 | BMFX8Y7 |
0.17% | NVCR | NOVOCURE LTD | -- | $153,732.09 | 6,991 | BYSS4X4 |
0.17% | RNA | AVIDITY BIOSCIENCES INC | -- | $153,636.00 | 5,208 | BMWHPY1 |
0.17% | VCEL | VERICEL CORP | -- | $152,447.55 | 3,153 | BSBMN89 |
0.16% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $148,993.00 | 3,925 | BF2YWG4 |
0.16% | MYGN | MYRIAD GENETICS INC | -- | $148,477.59 | 5,871 | 2614153 |
0.16% | DYN | DYNE THERAPEUTICS INC | -- | $146,648.64 | 5,298 | BN15WD1 |
0.16% | ARVN | ARVINAS INC | -- | $145,327.96 | 4,447 | BDZ30Q0 |
0.16% | VERA | VERA THERAPEUTICS INC | -- | $141,967.70 | 3,430 | BL55460 |
0.15% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $139,745.70 | 14,835 | BM9FJ13 |
0.15% | KYMR | KYMERA THERAPEUTICS INC | -- | $139,485.45 | 3,991 | BMPRZV5 |
0.15% | ADMA | ADMA BIOLOGICS INC | -- | $137,256.63 | 14,903 | B9NSBM2 |
0.15% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $136,527.20 | 3,140 | BNFWZS4 |
0.15% | GERN | GERON CORP | -- | $135,856.98 | 35,658 | 2370381 |
0.15% | DCPH | DECIPHERA PHARMACEUTICALS IN | -- | $134,326.96 | 5,276 | BZ1LFB2 |
0.15% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $133,706.82 | 5,911 | BDFKQ07 |
0.14% | BEAM | BEAM THERAPEUTICS INC | -- | $131,298.46 | 5,333 | BK6L288 |
0.14% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $125,924.78 | 3,667 | BCBVTX1 |
0.14% | SANA | SANA BIOTECHNOLOGY INC | -- | $125,703.27 | 14,399 | BMFJJ97 |
0.13% | KROS | KEROS THERAPEUTICS INC | -- | $122,858.00 | 2,350 | BM7V485 |
0.13% | APGE | APOGEE THERAPEUTICS INC | -- | $122,102.37 | 2,427 | BM9HHL5 |
0.13% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $119,955.79 | 2,251 | BLCD809 |
0.13% | NVAX | NOVAVAX INC | -- | $118,911.40 | 9,140 | BJDQXG4 |
0.13% | ARDX | ARDELYX INC | -- | $118,696.38 | 15,198 | BN89V40 |
0.13% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $116,934.96 | 3,804 | BDCBCD8 |
0.13% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $114,920.85 | 3,179 | BQS9486 |
0.12% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $112,589.21 | 5,549 | BN7Q7R7 |
0.12% | VCYT | VERACYTE INC | -- | $112,226.40 | 4,905 | BFTWZY0 |
0.12% | KURA | KURA ONCOLOGY INC | -- | $110,229.24 | 4,972 | BYZD465 |
0.12% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $110,108.80 | 6,080 | BKY5JZ8 |
0.12% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $107,527.12 | 3,704 | BKSGZN7 |
0.12% | INBX | INHIBRX INC | -- | $107,327.10 | 3,093 | BK1MBC3 |
0.11% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $103,916.10 | 3,571 | B72ZBG4 |
0.11% | FUSN | FUSION PHARMACEUTICALS INC | -- | $101,634.75 | 4,725 | BJK0NH0 |
0.11% | LGND | LIGAND PHARMACEUTICALS | -- | $99,485.36 | 1,156 | 2501578 |
0.11% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $97,782.16 | 8,638 | BMCWKZ2 |
0.10% | MORF | MORPHIC HOLDING INC | -- | $95,465.18 | 3,266 | BK8M4J4 |
0.10% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $94,779.41 | 8,531 | BRJZSK0 |
0.10% | PCRX | PACIRA BIOSCIENCES INC | -- | $93,661.98 | 3,039 | B3X26D8 |
0.10% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $92,233.68 | 5,704 | BLB0YH0 |
0.10% | XNCR | XENCOR INC | -- | $91,912.73 | 3,991 | BGCYWN8 |
0.10% | -- | AVADEL PHARMACEUTICALS | -- | $90,786.89 | 5,861 | BDGMC59 |
0.09% | VIR | VIR BIOTECHNOLOGY INC | -- | $85,789.41 | 8,817 | BK4PZ38 |
0.09% | TARS | TARSUS PHARMACEUTICALS INC | -- | $85,542.88 | 2,237 | BMH5RL1 |
0.09% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $84,566.48 | 13,466 | 2100362 |
0.09% | ANIP | ANI PHARMACEUTICALS INC | -- | $84,466.25 | 1,375 | BCDWBX6 |
0.09% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $82,405.68 | 3,252 | BKLXFX5 |
0.09% | GMAB | GENMAB A/S -SP ADR | -- | $82,055.26 | 2,737 | BBC9WC7 |
0.09% | MNKD | MANNKIND CORP | -- | $81,063.99 | 17,661 | BF081J4 |
0.09% | PRTA | PROTHENA CORP PLC | -- | $79,022.68 | 3,509 | B91XRN2 |
0.08% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $73,245.01 | 3,043 | BJDX8Y8 |
0.08% | AKRO | AKERO THERAPEUTICS INC | -- | $73,225.92 | 3,676 | BK7Y2V9 |
0.08% | ABCL | ABCELLERA BIOLOGICS INC | -- | $69,596.80 | 19,120 | BL53SR3 |
0.07% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $67,764.89 | 2,087 | BX7RSN3 |
0.07% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $66,258.00 | 10,225 | B3MZ6K5 |
0.07% | INVA | INNOVIVA INC | -- | $65,981.42 | 4,129 | BDDXF67 |
0.07% | CGEM | CULLINAN THERAPEUTICS INC | -- | $64,736.98 | 2,794 | BM90J52 |
0.07% | ZLAB | ZAI LAB LTD-ADR | -- | $62,739.60 | 3,234 | BD9GVY0 |
0.07% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $61,954.56 | 2,689 | BMFD115 |
0.07% | GRFS | GRIFOLS SA-ADR | -- | $61,330.50 | 7,965 | B8K7T65 |
0.07% | PLRX | PLIANT THERAPEUTICS INC | -- | $60,041.64 | 3,932 | BMDWW66 |
0.06% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $58,852.88 | 4,712 | BFZQ0L8 |
0.06% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $58,199.20 | 6,326 | BKX9VD3 |
0.06% | VRNA | VERONA PHARMA PLC - ADR | -- | $57,694.00 | 4,438 | BYWPZK5 |
0.06% | RLAY | RELAY THERAPEUTICS INC | -- | $56,891.52 | 8,568 | BN2R582 |
0.06% | SPRY | ARS PHARMACEUTICALS INC | -- | $56,627.13 | 6,271 | BMCR7V2 |
0.06% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $55,956.52 | 4,636 | BMQ5T49 |
0.06% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $54,397.44 | 9,444 | BFWLC09 |
0.06% | PRME | PRIME MEDICINE INC | -- | $53,900.04 | 7,613 | BPBJFM7 |
0.06% | NRIX | NURIX THERAPEUTICS INC | -- | $52,955.28 | 3,192 | BMVLGP2 |
0.06% | ETNB | 89BIO INC | -- | $52,539.44 | 6,088 | BK1K484 |
0.06% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $52,055.44 | 1,748 | BKC9SX3 |
0.06% | KNSA | KINIKSA PHARMACEUTICALS-A | -- | $51,599.70 | 2,610 | BD0MGM0 |
0.06% | CVAC | CUREVAC NV | -- | $51,027.29 | 14,621 | BN4RD42 |
0.06% | EOLS | EVOLUS INC | -- | $50,731.47 | 3,733 | BDRJH21 |
0.06% | IRON | DISC MEDICINE INC | -- | $50,619.14 | 1,573 | BMGJZJ8 |
0.06% | COGT | COGENT BIOSCIENCES INC | -- | $50,487.84 | 6,786 | BLR6XK8 |
0.05% | TNGX | TANGO THERAPEUTICS INC | -- | $50,098.24 | 6,662 | BP2P6L0 |
0.05% | WVE | WAVE LIFE SCIENCES LTD | -- | $49,885.94 | 7,969 | BYZG9R0 |
0.05% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $49,726.08 | 2,328 | BKDQKM6 |
0.05% | RGNX | REGENXBIO INC | -- | $46,434.96 | 2,904 | BZ0G875 |
0.05% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $46,253.55 | 3,255 | BLN7XQ1 |
0.05% | SAGE | SAGE THERAPEUTICS INC | -- | $45,969.30 | 3,929 | BP4GNK9 |
0.05% | LYEL | LYELL IMMUNOPHARMA INC | -- | $45,467.56 | 16,594 | BN6MB18 |
0.05% | OCUL | OCULAR THERAPEUTIX INC | -- | $44,424.00 | 7,200 | BNZB1X8 |
0.05% | ANAB | ANAPTYSBIO INC | -- | $43,546.59 | 1,737 | BDRW1L7 |
0.05% | CSTL | CASTLE BIOSCIENCES INC | -- | $43,510.80 | 1,795 | BKLCWZ3 |
0.05% | HUMA | HUMACYTE INC | -- | $42,841.44 | 6,768 | BMYTJP4 |
0.05% | ITOS | ITEOS THERAPEUTICS INC | -- | $42,146.75 | 2,335 | BMWXFT4 |
0.05% | ZYME | ZYMEWORKS INC | -- | $41,696.64 | 4,572 | BPCQZY9 |
0.04% | HCM | HUTCHMED CHINA-ADR | -- | $40,803.91 | 2,023 | BYXV9H7 |
0.04% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $40,361.66 | 9,194 | BFMLGR4 |
0.04% | ORIC | ORIC PHARMACEUTICALS INC | -- | $40,304.00 | 4,400 | BKVDFF7 |
0.04% | SVRA | SAVARA INC | -- | $39,603.20 | 8,840 | BYXGN81 |
0.04% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $39,430.14 | 3,741 | BJLKVS6 |
0.04% | HROW | HARROW INC | -- | $38,413.92 | 2,292 | BHNDW86 |
0.04% | GLPG | GALAPAGOS NV-SPON ADR | -- | $38,193.07 | 1,289 | B292NQ7 |
0.04% | PETQ | PETIQ INC | -- | $38,062.82 | 1,906 | BDH65C8 |
0.04% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $37,745.92 | 3,188 | BMGS7L1 |
0.04% | TSHA | TAYSHA GENE THERAPIES INC | -- | $37,735.08 | 12,212 | BNC1BX1 |
0.04% | THRD | THIRD HARMONIC BIO INC | -- | $36,575.87 | 2,638 | BNNPQY8 |
0.04% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $35,414.16 | 3,599 | BMZ4LN0 |
0.04% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $35,352.02 | 17,501 | B4N8MH9 |
0.04% | SIGA | SIGA TECHNOLOGIES INC | -- | $35,318.01 | 4,641 | 2107437 |
0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $34,931.00 | 2,687 | BP9N0G0 |
0.04% | CABA | CABALETTA BIO INC | -- | $34,567.65 | 2,799 | BK5MWR1 |
0.04% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $34,197.53 | 9,473 | BJ5FZ74 |
0.04% | ALEC | ALECTOR INC | -- | $34,021.76 | 6,254 | BJ4LDC4 |
0.04% | OABI | OMNIAB INC | -- | $33,784.40 | 7,592 | BN13S71 |
0.04% | YMAB | Y-MABS THERAPEUTICS INC | -- | $33,199.20 | 2,862 | BG31GH0 |
0.04% | VERV | VERVE THERAPEUTICS INC | -- | $32,662.76 | 5,462 | BNKGXX2 |
0.04% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $32,659.34 | 3,682 | BLB0YQ9 |
0.04% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $32,636.96 | 10,952 | BZ0QMB7 |
0.04% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $32,386.64 | 2,717 | BD06CS0 |
0.03% | MXCT | MAXCYTE INC | -- | $31,606.56 | 6,768 | BKMQF66 |
0.03% | FULC | FULCRUM THERAPEUTICS INC | -- | $30,547.30 | 4,046 | BJDX8Z9 |
0.03% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $30,436.76 | 10,988 | BFZNYB7 |
0.03% | TBPH | THERAVANCE BIOPHARMA INC | -- | $30,229.66 | 3,254 | BMNDK09 |
0.03% | TVTX | TRAVERE THERAPEUTICS INC | -- | $30,118.20 | 4,970 | BLFGJD5 |
0.03% | EDIT | EDITAS MEDICINE INC | -- | $30,044.52 | 5,346 | BZ8FPH3 |
0.03% | VYGR | VOYAGER THERAPEUTICS INC | -- | $29,892.78 | 3,546 | BY7RB53 |
0.03% | BMEA | BIOMEA FUSION INC | -- | $28,506.96 | 2,329 | BNKF6N0 |
0.03% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $28,210.26 | 15,938 | BWFZX59 |
0.03% | SLRN | ACELYRIN INC | -- | $27,911.62 | 6,358 | BQPF874 |
0.03% | URGN | UROGEN PHARMA LTD | -- | $26,677.96 | 2,018 | BZ7PJQ1 |
0.03% | REPL | REPLIMUNE GROUP INC | -- | $25,837.28 | 4,012 | BDDVW37 |
0.03% | TRML | TOURMALINE BIO INC | -- | $25,161.92 | 1,673 | BQ80NC6 |
0.03% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $24,416.80 | 1,327 | BL95N25 |
0.03% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $24,397.10 | 5,362 | BYTYP72 |
0.03% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $24,101.50 | 8,170 | BNG1NK8 |
0.03% | TERN | TERNS PHARMACEUTICALS INC | -- | $23,806.50 | 4,035 | BMDJ0C9 |
0.03% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $23,707.92 | 4,152 | BFYQFJ2 |
0.02% | PGEN | PRECIGEN INC | -- | $22,436.04 | 16,258 | BKM5C84 |
0.02% | AMRN | AMARIN CORP PLC -ADR | -- | $21,922.26 | 25,198 | 2301938 |
0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $20,582.88 | 3,756 | B12W3P6 |
0.02% | ACIU | AC IMMUNE SA | -- | $20,526.90 | 6,455 | BZC0D70 |
0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $20,064.05 | 5,497 | BLN9Z50 |
0.02% | CRBU | CARIBOU BIOSCIENCES INC | -- | $19,584.03 | 5,777 | BNYJR68 |
0.02% | ERAS | ERASCA INC | -- | $19,441.93 | 9,869 | BNLYBF3 |
0.02% | ATAI | ATAI LIFE SCIENCES NV | -- | $18,543.24 | 10,844 | BN6M8F1 |
0.02% | VTYX | VENTYX BIOSCIENCES INC | -- | $18,314.56 | 3,872 | BMG99Y1 |
0.02% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $17,865.54 | 9,023 | BLR7H87 |
0.02% | MGNX | MACROGENICS INC | -- | $17,695.71 | 4,054 | BFDV8K0 |
0.02% | RVNC | REVANCE THERAPEUTICS INC | -- | $17,398.22 | 5,761 | BJFSR99 |
0.02% | EXAI | EXSCIENTIA PLC | -- | $16,385.20 | 3,151 | BP48134 |
0.02% | QURE | UNIQURE NV | -- | $15,671.28 | 3,128 | BJFSR88 |
0.02% | CHRS | COHERUS BIOSCIENCES INC | -- | $15,418.76 | 7,273 | BRK0149 |
0.02% | OVID | OVID THERAPEUTICS INC | -- | $14,543.55 | 4,617 | BYPFK63 |
0.01% | BLUE | BLUEBIRD BIO INC | -- | $12,805.99 | 12,433 | BBFL7S1 |
0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $12,088.67 | 20,601 | BM9CKX3 |
0.01% | RAPT | RAPT THERAPEUTICS INC | -- | $9,069.80 | 2,245 | BK5T6R0 |
0.01% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $8,099.58 | 4,426 | BPCK358 |
0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $5,515.65 | 4,635 | BYV2W40 |
0.01% | MRNS | MARINUS PHARMACEUTICALS INC | -- | $4,742.78 | 3,566 | BM8MVZ3 |
-- | RPHM | RENEO PHARMACEUTICALS INC | -- | $3,809.75 | 2,177 | BMHR7T5 |
-- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
-- | -- | TREASURY BILL | -- | $14,825,666.70 | 15,000,000 | BRYQ9Y9 |
-- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $13,551,393.58 | 13,551,394 | -- |
Index
as of 3/28/2024
- Total Number of Companies218
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$6.77 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
- 2024
- 2023
- 2022
Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
---|